Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    "methodist hospital" | Open Studies | "Anemia, Hemolytic, Congenital" | United States, Texas | Houston
Show Display Options
Rank Status Study
1 Not yet recruiting STRIDE Biorepository
Condition: Anemia, Sickle Cell
Intervention: Procedure: Blood draw
2 Not yet recruiting Bone Marrow Transplantation vs Standard of Care in Patients With Severe Sickle Cell Disease (BMT CTN 1503)
Condition: Sickle Cell Disease
Interventions: Drug: Busulfan;   Drug: Fludarabine;   Drug: r-ATG;   Procedure: Bone Marrow Transplant;   Drug: Tacrolimus;   Drug: Methotrexate;   Procedure: Standard of Care

Indicates status has not been verified in more than two years